Hipertensión arterial en la mujer
DOI:
https://doi.org/10.24197/aramcv.56.2020.270-301Palabras clave:
Cardiovascular, hipertensión, riesgos, mujeresResumen
La enfermedad cardiovascular es uno de los problemas de salud más importantes en las mujeres en todo el mundo y la hipertensión arterial (HTA) se encuentra entre los principales factores de riesgo para desarrollar esta enfermedad (Hage FG, et al. 2013), representando 1 de cada 5 muertes de mujeres en los Estados Unidos (Wenger NK, et al. 2018). Sin embargo, su tratamiento y control no es óptimo en las mujeres, por lo que la hipertensión es probablemente el factor de riesgo cardiovascular más descuidado.
Los datos del Instituto Nacional de Estadística, referidos al año 2018 (Instituto Nacional de Estadística, 2019) muestran que la enfermedad cardiovascular seguía siendo la 1ª causa de muerte en España, 230,5 muertes por cada 100.000 habitantes; Un 6% más de mujeres mueren cada año que los hombres por enfermedades cardiovasculares. En Castilla y León el número de defunciones fue de 199,8 por cada 100.000 habitantes.
Descargas
Citas
Abramson BL, Srivaratharajab K, Davis LL, Parapid B. Women and Hypertension: Beyond the 2017 Guideline for Prevention, Detection, Evaluation, and Management of High Blood Pressure in Adults. American College of Cardiology. Expert Analysis. Jul 27, 2018. https://www.acc.org/latest-in-cardiology/articles/2018/07/27/09/02/women-andhypertension (revisado en octubre 2019).
Ahmad A, Oparil S. Hypertension in women. Recent Advances and Lingering Questions. Hypertension 2017;70:19-26.
ALLHAT Officers and Coordinators for the ALLHAT Collaborative Research Group. Mayor outcomes in high-risk hypertensive patients randomized to angiotensin-converting enzyme inhibitor or calcium cannel blocker vs diuretic: The Antihipertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT). JAMA 2002;288(23):2981-2997.
August P, Oparil S. Hypertension in women. J Clin Endocrinol Metab 1999;84:1862-1866.
Backeljauw P. Clinical manifestations and diagnosis of Turner syndrome. UpToDate. Revisado en Enero de 2020.
Basile J, Bloch MJ. Effect of hormonal contraceptives and postmenopausal hormone therapy on blood pressure. UpToDate. Nov 01, 2018. Revisado Feb 2020.
Becket NS, Peters R, Fletcher AE, et al. Treatment of hypertension in patientes 80 years of age or older. N Engl J Med 2009:358:1887-1898.
Benjamin EJ, Virani SS, Callaway CW, et al. Heart Disease And Stroke Statistics-2018 Update. Circulation 2018;137:367-3492.
Chen KHM, Henderson VW, Stolwyk RJ, et al. Prehypertension in midlife is associated with worse cognition a decade later in middle-aged and older women. Age Ageing 2015;44:439-445.
Conn VS, Ruppar TM, Enriquez M, Cooper PS. Patient-Centered Outcomes of Medication Adherence Interventions: Systematic Review and Meta-Analysis. Value Health 2016;19(2):277-285.
Douglas PS, Poppas A. Overview of cardiovascular risk factors in women. UpToDate Nov 22, 2019. Revisado en Feb. 2020.
Eugene AR. Metoprolol dose equivalence in adult men and women based on gender differences: pharmacokinetic modeling and simulations. Med Sci 2016;4:18-26.
Farland LV, Grodstein F, Srouji SS, et al. Infertility, fertility treatment, and risk of hypertension. Fertil Steril 2015;104:391-397
Flynn JT, Kaelber DC, Baker-Smith CM, et al. Clinical Practice Guideline for Screening and Management of High Blood Pressure in Children and Adolescents. Pediatrics 2017;140(3):e20171904
Ford E. Trends in mortality from all causes and cardiovascular disease among hypertensive and nonhypertensive adults in the United States. Circulation 2011;123:1737-1744.
Foy CG, Lovato LC, Vitolins MZ, et al. Gender, blood pressure, and cardiovascular and renal outcomes in adults with hypertension from the Systolic Blood Presure Interventional Trial. J Hypertension 2018;36(4):904-915.
Gierach GL, Johson BD, Bairey Merz CN, et al.; WISE Study Group. Hypertension, menopause, and coronary artery disease risk in the Women´s Ischemia Syndrome Evaluation Study ((WISE). J Am Coll Cardiol 2006;47:S50-58.
González O, Mozo F, Ugarte I et al. Hipertensión arterial acelerada por anovulatorios transdérmicos. Nefrología 2006;26(5):633-634.
Grimm RH Jr, Grandits GA, Prineas RJ, et al. Long-term effets on sexual function of five antihipertensive drugs and nutritional hygienic treatment in hypertensive men and women. Treatment of Mild Hypertensive Study (TOMHS). Hypertension 1997;29:8-14.
Grupo de trabajo de la Guía de Práctica Clínica de Anticoncepción Hormonal e Intrauterina. Ministerio de Sanidad, Consumo y Bienestar Social. Instituto Aragonés de Ciencias de la Salud; 2019. Guías de Práctica Clínica en el SNS.
Gudmundsdottir H, Hoieggen A, Stenehjem A, et al. Hypertension in women: Latest findings and clinical implications. Ther Adv Chronic Dis 2012,;3(3):137-146
Hage FG, Mansur SJ, Xing D, et al. Hypertension in women. Kidney International Supplements 2013;3:352-356
Halls PS, Nah G, Vittinghoff E, et al. Relation of pregnancy loss to risk of cardiovascular disease in parous postmenopausal women (From the Women´s Healh Iniciative). Am J Cardiol 2019;123(10):1620-1625.
Hickson SS, Miles KL, McDonnell BJ, et al. Use of the oral contraceptive pill is associated with increased artery stiffness in young women: the ENIGMA study. J Hypertens 2011;29(6):1155-1159.
Holt E, Joyce C, Dornelles A, et al. Sex differences in barriers to antihypertensive treatment medication adherence: findings from the cohort study of medication adherence among olders adults. J Am Geriatr Soc 2013;61:558-564.
Instituto Nacional de Estadística. Notas de prensa. 19 de diciembre de 2019. Defunciones según la causa de la muerte. Consultado en Enero de 2020.
Jaffe MG, Lee GA, Young JD, et al. Improved blood pressure control associated with a large-scale hypertension program. JAMA 2013;310(7):699-705.
Keyhani S, Scobie JV, Herbert PL, et al. Gender disparities in blood pressure control and cardiovascular care in a national sample of ambulatory care visits. Hypertension 2008;51:1149-1155.
Kjeldsen SE, Hedner T, Syvertsen JO, et al. Influence of age, sex and blood pressure on the principals endpoints of Nordic Diltiazem (NORDIL) Study. J Hypertens 2002;20:1231-1237.
Kjeldsen SE, Warnold I, Hansson L. Influence of gender on prevention of myocardial infarction by antihypertensives and acetylsalicylic acid: the HOT study. J Gend Specif Med 2000;3:35-38.
Kuznetsova T, Staessen JA, Brand E, et al. Sodium excretion as a modulator of genetic associations with cardiovascular phenotypes in the European Project on Genes in Hypertension. Journal of Hypertension 2006;24:235-242.
Lalouel JM. Large-scale search for genes predisposing to essential hypertension. Am J Hypert 2003;16(2):163-166.
Margolis KL, O´Connor PJ, Morgan TM, et al. Outcomes of combined cardiovascular risk factor management strategies in type 2 diabetes: the ACCORD randomized trial. Diabetes Care 2014;37(6):1721-1728.
Mass AHEM. Hypertension in women: no “silent” lady-killer. e-Journal of Cardiology Practice, 2019;17(21). http://www.escardio.org/Journals/E-Journal-of-Cardiology-Practice/Volume-17/hypertension-in-womwn-no-silent-lady-killer (revisado en Diciembre de 2019).
Mazón P, Bertemeu V. Hipertensión arterial en la mujer en España: análisis de los registros de la Sección de Hipertensión Arterial de la Sociedad Española de Cardiología. Rev Esp Cardiol Supl. 2008;8:30D-37D
Menéndez E, Delgado E, Fernández-Vega F, et al. Prevalencia, diagnóstico, tratamiento y control de la hipertensión arterial en España. Resultados del estudio Di@bet.es. Rev Esp Cardiol 2016;69(6):572-578.
Molina A. Visión actual de la hipertensión arterial en adultos. Real Academia de Medicina y Cirugía de Valladolid. 26 de Abril de 2019. Cargraf Artes Gráficas. Valladolid.
Muntner P, Carey RM, Gidding S, et al. Potencial U.S. Population Impact of the 2017 ACC/AHA High Blood Pressure Guideline. J Am Coll Cardiol 2018;71(2):109-118.
Neaton JD, Grimm RH Jr, Prineas RJ, et al. Treatment of Mild Hypertension Study. Final results. Treatment of Mild Hypertension Study Research Group (TOMHS). JAMA 1993;270:713-724.
Orte LM, Alcázar de la Ossa JM. Hipertensión arterial secundaria. En: Lorenzo V, López Gómez JM (Eds) Nefrología al Día. http://dev.nefro.elsevier.es/es-monografias-nefrologia-dia-articulo-hipertensin-arterial-secundaria-24.
Os I, Bratland B, Dahlof B, et al. Female preponderance for lisinopril-induced cough in hypertension. Am J Hypertens 1994;7:1012-1015.
Os I, Oparil S, Gerdts E, Hoieggen A. Essential hypertension in women. Blood Press 2004;13:272-278.
Os I, Franco V, Kjeldsen SE, et al. Effects of losartan in women with hypertension and left ventricular hypertrophy: results from Losartan Intervention for Endpoint Reduction in Hypertension Study. Hypertension 2008;51:1103-1108.
Pardell H, Armario P,Hernández del Rey R. Tabaco, presión arterial y riesgo cardiovascular. Hipertensión y riesgo cardiovascular, 2003; 20(5):226-233.
Puttnam R, Davis BR, Pressel SL, et al. Association of 3 different antihypertensive medications with hip and pelvis fracture risk in older adults: secondary analysis of a randomized clinical trial. JAMA Intern Med 2017;177:67-76.
Ramirez LA, Sullivan J. Sex Differences in Hypertension: Where We Have Been and Where We Are Going. Am J Hypertension 2018;31(12):1247-1254.
Roberts JM, August PA, Bakris G, et al. Report of the American College of Obstetrician and Ginecologists’Task Force on Hypertension in Pregnancy. Obstet Gynecol 2013;122:1122-1131.
Roerecke M, Kaczorowski J, Tobe SW, et al. The effect of a reduction in alcohol consumption on blood pressure: a systematic review and meta-analysis. Lancet Public Health 2017;2:e108-120.
Rosano GMC, Lewis B, Agewall S et al. Gender differences in the effect of cardiovascular drugs: a position document of the Working Group on Pharmacology and Drug Therapy of the ESC. Eur Heart J 2015;36:2677-2680.
Sacks FM, Svetkey LP, Vollmer WM, et al. Effects on blood pressure of reduced dietary sodium and the dietary approaches to stop hypertension (DASH) diet. N Engl J Med 2001;344(1):3-10.
Son WM, Sung KD, Cho JM, et al. Combined exercise reduces arterial stiffness, blood pressure, and blood markers for cardiovascular risk in postmenopausal women with hypertension. Menopause 2017;24:262-268.
Sorlie PD, Allison MA, Avilés-Santa ML, et al. Prevalence of hypertension, awareness, treatment, and control in the Hispanic Community Health Study/Study of Latinos. Am J Hypertension 2014;27(6):793-800.
Steward KJ, Sung J, Silber HA, et al. Exaggerated exercise blood pressure is related to impaired endothelial vasodilatador function. Am J Hypertens 2004;17:314-320.
Textor S. Evaluation of secondary hypertension. UpToDate. Revisado en Enero de 2020.
Turnbull F, Woodward M, Neal B, et al. Do men and women respond differently to blood pressure-lowering treatment? Results of prospectively designed overviews of randomized trials. Eur Heart J 2008;29:2669-2680.
Turnbull F, Woodward M, Anna V. Effectiveness of blood pressure lowering: evidence-based comparisons between men and women. Expert Rev Cardiovasc Ther 2010;8(2):199-209.
Ueno K, Sato H. Sex-related differences in pharmacokinetics and pharmacodynamics of anti-hypertensive drugs. Hypertens Res 2012;35:245-250.
Vasan RS, Massaro JM, Wilson PW, et al. Antecedent Blood Pressure and Risk of Cardiovascular Disease. The Framingham Heart Study. Circulation 2002;105:48-53.
Wassertheil-Smoller S, Anderson G, Psaty BM, et al. Hypertension and Its Treatment in Postmanopausal Women. Baseline Data from the Women´s Health Initiative. Hypertension 2000;36:780-789.
Wenger NK, Arnold A, Bairey Merz CN, et al. Hypertension Across a Woman´s Life Cycle. J Am Coll Cardiol 2018;71(16):1797-1813.
Wenger NK, Ferdinand KC, Bairey Merz CN, et al. Women, Hypertension, and the Systolic Blood Pressure Intervention Trial. Am J Med 2016;129:1030-1036.
Whelton PK, Carey RM, Aronow WS, et al. 2017 ACC/AHA/AAPA/ABC/ACPM/AGC/ A Guideline for the Prevention, Detection, Evaluation, and Management of High Blood Pressure in Adults: A Report of the American College of cardiology/American Heart association Task Force on Clinical Practice Guidelines. Hypertension 2018;71:1269-1324.
Williams B, Mancia G, Spiering W, et al. 2018 ESC/ESH Guidelines for the management of arterial hypertension. The Task Force for the management of arterial hypertension of the European Society of Cardiology (ESC) and the European Society of Hypertension (ESH). European Heart Journal 2018;39: 3021–3104.
Williamson JD, Supiano MA, Applegate WB, et al. Intensive vs Standar Blood Pressure Control and cardiovascular Disease Outcomes in Adults Aged ≥75 Years: A Randomized Clinical Trial. JAMA 2016:315(24):2673-2682.
Wing LM, Reid CM, Ryan P et al. A comparison of outcomes with angiotensin-converting enzyme inhibitors and diuretics for hypertension in the elderly. N Engl J Med 2003;348:583-592.
Wright JT Jr, Williamson JD, Whelton PK, et al. The SPRINT Research Group. A randomized trial of intensive versus standard blood-pressure control. N Engl J Med 2015:373:2103-2116.
Wood AM, Kaptoge S, Butterworth AS, et al. Risk thresholds for alcohol consumption: combined analysis of individual-participant data for 599912 current drinkers in 83 prospective studies. Lancet 2018;391:1513-1523.
Yoon SS, Carroll MD, Fryar CD. Hypertension Prevalence and Control Among Adults: United States, 2011-2014. NCHS Data Brief 2015; Nº220:1-8.
Zanchetti A, Julius S, Kjeldsen S, et al. Outcomes in subgroups of hypertensive patients treated with regimens based on valsartan and amlodipine: An analysis of findings from the VALUE trial. J Hypertens 2006;24(11):2163-2168.
Descargas
Publicado
Cómo citar
Número
Sección
Licencia
Esta obra está bajo una licencia internacional Creative Commons Atribución 4.0.
Todos los trabajos publicados en la revista Anales de la Real Academia de Cirugía y Medicina están sujetos a una licencia Licencia Creative Commons Atribución 4.0 Internacional (CC BY 4.0).
Los autores continúan como propietarios de sus trabajos, y pueden volver a publicar sus artículos en otro medio sin tener que solicitar autorización, siempre y cuando indiquen que el trabajo fue publicado originariamente en la revista Anales de la Real Academia de Cirugía y Medicina.
